Long Island Jewish Medical Center

Alentis Therapeutics Appoints Lung Experts Professors Tony Mok and Steven Nathan to its Scientific Advisory Board

Retrieved on: 
Thursday, October 5, 2023

Alentis Therapeutics (“Alentis”), the clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, announced today the appointment of Tony Mok, Professor of Clinical Oncology at the Chinese University of Hong Kong and Steven Nathan, Professor at the University of Virginia as members of its Scientific Advisory Board.

Key Points: 
  • Alentis Therapeutics (“Alentis”), the clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, announced today the appointment of Tony Mok, Professor of Clinical Oncology at the Chinese University of Hong Kong and Steven Nathan, Professor at the University of Virginia as members of its Scientific Advisory Board.
  • View the full release here: https://www.businesswire.com/news/home/20231005193827/en/
    Lung experts Prof. Steven Nathan and Prof. Tony Mok join Alentis Therapeutics' Scientific Advisory Board.
  • (Photo: Alentis Therapeutics)
    “Tony and Steven have exceptional expertise in lung cancer and lung fibrosis, respectively, which will be of great value to our Scientific Advisory Board,” said Dr. Luigi Manenti, Chief Medical Officer of Alentis.
  • Prof. Steven Nathan is the Medical Director of the Advanced Lung Disease and Lung Transplant Program at Inova Fairfax Hospital and is a Professor at the University of Virginia.

Northwell Nurse Sandra Lindsay is First for Pfizer COVID Vaccine – Again

Retrieved on: 
Wednesday, September 13, 2023

Sandra Lindsay, RN , became a global phenomenon on December 14, 2020, when the Northwell Health critical care nurse director received the Pfizer-BioNTech COVID-19 vaccine.

Key Points: 
  • Sandra Lindsay, RN , became a global phenomenon on December 14, 2020, when the Northwell Health critical care nurse director received the Pfizer-BioNTech COVID-19 vaccine.
  • View the full release here: https://www.businesswire.com/news/home/20230913186771/en/
    Dr. Michelle Chester, senior director of Employee Health Services at Northwell Health, administers the 2023-24 Pfizer COVID-19 vaccine to Nurse Sandra Lindsay, vice president of public health advocacy at Northwell.
  • Credit Northwell Health
    Nearly three years later, Nurse Lindsay volunteered to be the first American to receive this season’s shot: Pfizer-BioNTech 2023-24 COVID-19 vaccine.
  • “It’s important that people understand that COVID is still around and can still severely affect an individual,” said Nurse Lindsay.

Babylon Dental Care proud to welcome Dr. Unsa Malik

Retrieved on: 
Tuesday, September 5, 2023

WEST BABYLON, N.Y., Sept. 5, 2023 /PRNewswire/ -- Babylon Dental Care is excited to announce that Dr. Unsa Malik will join their team as their newest dentist.

Key Points: 
  • WEST BABYLON, N.Y., Sept. 5, 2023 /PRNewswire/ -- Babylon Dental Care is excited to announce that Dr. Unsa Malik will join their team as their newest dentist.
  • A Suffolk County native, Dr. Malik is returning home to help BDC in its mission to provide exceptional dental care to her fellow Long Islanders.
  • "We're so happy to have found a like-minded provider who knows Long Island and understands our patients," said Jenn Brown, the Director of Operations for Babylon Dental Care.
  • Dr. Unsa Malik and the other amazing dentists with Babylon Dental Care are accepting appointments and eager to meet new patients.

Northwell Health is New York’s most awarded health system by U.S. News

Retrieved on: 
Tuesday, August 1, 2023

Two other Northwell hospitals also placed in the top 10 in state rankings, and dozens of programs across the health system were also ranked incredibly well.

Key Points: 
  • Two other Northwell hospitals also placed in the top 10 in state rankings, and dozens of programs across the health system were also ranked incredibly well.
  • View the full release here: https://www.businesswire.com/news/home/20230801769477/en/
    Dozens of Northwell specialty programs were ranked among the best in the nation by U.S. News & World Report.
  • “We are proud to see Northwell recognized as New York State’s most-awarded health system.
  • The health system has more hospitals ranked as the top in the state, and has more specialties ranked nationally as well.

COVID-19 patients with cardiovascular disease more likely to develop blood clots post-hospital discharge, Feinstein Institutes study

Retrieved on: 
Tuesday, May 23, 2023

To better explain the prevalence and cause of clots, researchers from The Feinstein Institutes for Medical Research investigated the rates of clotting 90 days after patients leave the hospital.

Key Points: 
  • To better explain the prevalence and cause of clots, researchers from The Feinstein Institutes for Medical Research investigated the rates of clotting 90 days after patients leave the hospital.
  • “We have been studying how COVID-19 impacts our patients, both inpatient and post-discharge with blood clots, since the beginning of the pandemic,” said Dr. Spyropoulos.
  • “The prevalence of blood clots increases for patients with, and recovering from, COVID-19,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research.
  • Spyropoulos and Giannis helps clinicians better recognize which patients are most at risk and how to give them superior care.”

BioRestorative Therapies and Northwell Health Enter into Agreement to Participate in the Company’s Phase 2 Clinical Trial

Retrieved on: 
Monday, May 8, 2023

(“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a clinical stage company focused on stem cell-based therapies, today announced that it has signed a clinical trial agreement with Northwell Health, New York State's largest health care provider and private employer, and Northwell’s Feinstein Institutes for Medical Research.

Key Points: 
  • (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a clinical stage company focused on stem cell-based therapies, today announced that it has signed a clinical trial agreement with Northwell Health, New York State's largest health care provider and private employer, and Northwell’s Feinstein Institutes for Medical Research.
  • The signing of the agreement will allow Northwell Health to participate in BioRestorative Therapies ongoing Phase 2 clinical trial targeting chronic lumber disc disease (cLDD).
  • BRTX-100 is currently being evaluated in connection with a Phase 2 clinical trial to treat cLDD.
  • The partnership will enable Northwell to participate in BioRestorative’s clinical trial targeting patients suffering from chronic lumbar disc disease.

Philips and Northwell Health partner to standardize and future-proof patient monitoring across the enterprise

Retrieved on: 
Tuesday, April 4, 2023

This will not only allow Northwell Health to lay the foundation for a future-proof, enterprise-wide platform, but the system will also allow them to support innovative technologies as they evolve and give them the flexibility to scale their patient monitoring systems quickly and efficiently.

Key Points: 
  • This will not only allow Northwell Health to lay the foundation for a future-proof, enterprise-wide platform, but the system will also allow them to support innovative technologies as they evolve and give them the flexibility to scale their patient monitoring systems quickly and efficiently.
  • Northwell Health is also pioneering research at the Feinstein Institutes, including national clinical trial sites for treating lupus, rheumatoid arthritis, and paralysis.
  • “The new Philips system gives us an enterprise-wide platform that centralizes our patient monitoring and allows us to see what is happening at each bedside.
  • With the Philips patient monitoring platform, they have a vendor-agnostic system that will leverage the health system’s existing network infrastructure, along with Philips Software Evolution Services, to standardize care and ensure that Northwell Health is at the forefront of monitoring innovation.

Dr. Lawrence Kirschenbaum Joins Physician Partners of America- West Palm Beach, FL

Retrieved on: 
Friday, March 31, 2023

WEST PALM BEACH, Fla., March 31, 2023 /PRNewswire-PRWeb/ -- Physician Partners of America (PPOA) is pleased to announce that interventional pain management specialist Lawrence Kirschenbaum, M.D., has joined the company's West Palm Beach, Florida pain management practice. He began seeing patients on March 6 at the office, located at 6910 S. Dixie Hwy, Suite 102, West Palm Beach, FL 33405.

Key Points: 
  • WEST PALM BEACH, Fla., March 31, 2023 /PRNewswire-PRWeb/ -- Physician Partners of America (PPOA) is pleased to announce that interventional pain management specialist Lawrence Kirschenbaum, M.D., has joined the company's West Palm Beach, Florida pain management practice.
  • He began seeing patients on March 6 at the office, located at 6910 S. Dixie Hwy, Suite 102, West Palm Beach, FL 33405.
  • Dr. Lawrence Kirschenbaum, is a notably experienced, board-certified, fellowship trained Interventional Pain Management Physician.
  • In addition to his practice of interventional pain management, Dr. Kirschenbaum remains an Associate Clinical Professor at the Yale University School of Medicine.

Northwell selects Epic to deliver next-generation electronic health record

Retrieved on: 
Monday, March 20, 2023

Northwell Health today announced an agreement with health care software leader Epic to implement the health system’s next generation electronic health record (EHR) as part of its ongoing digital transformation to ensure a more seamless patient and team member experience.

Key Points: 
  • Northwell Health today announced an agreement with health care software leader Epic to implement the health system’s next generation electronic health record (EHR) as part of its ongoing digital transformation to ensure a more seamless patient and team member experience.
  • View the full release here: https://www.businesswire.com/news/home/20230320005438/en/
    Northwell Health staff update electronic health records of patients at Long Island Jewish Medical Center.
  • Photo Credit Northwell Health
    Epic, the industry-leading EHR provider based in Wisconsin, provides an integrated solution that will result in one patient record across every Northwell venue of care and drive enhanced care coordination.
  • “We are excited for the collaboration and possibilities with Epic,” said Sophy Lu , senior vice president and chief information officer at Northwell.

Feinstein Institutes’ Study Discovers That Mitochondrial Transplantation Improves Survival and Outcomes After Cardiac Arrest

Retrieved on: 
Thursday, March 16, 2023

Through a series of studies, researchers at The Feinstein Institutes for Medical Research have shown that mitochondria transplantation (MTx), delivering new mitochondria to critical tissues, can improve survival and neurological outcomes after cardiac arrest.

Key Points: 
  • Through a series of studies, researchers at The Feinstein Institutes for Medical Research have shown that mitochondria transplantation (MTx), delivering new mitochondria to critical tissues, can improve survival and neurological outcomes after cardiac arrest.
  • View the full release here: https://www.businesswire.com/news/home/20230316005460/en/
    Dr. Lance Becker led the new research on mitochondria transplantation.
  • “Mitochondria transplantation is an untapped area of research and therapy that could lead to clinical benefits to restore much-needed energy.
  • The results showed that the animals receiving fresh mitochondria infusion improved neurological function and survival, from 55 percent to 91 percent, after cardiac arrest and resuscitation.